Net Income (Loss) Per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares |
3 Months Ended | |
|---|---|---|
Mar. 31, 2026 |
Mar. 31, 2025 |
|
| Total securities excluded from the calculation of weighted average number of shares of common stock outstanding (in shares) | 3,005,545 | 13,218,268 |
| Awards under equity incentive plans | ||
| Total securities excluded from the calculation of weighted average number of shares of common stock outstanding (in shares) | 3,005,545 | 7,734,741 |
| Common stock warrants | ||
| Total securities excluded from the calculation of weighted average number of shares of common stock outstanding (in shares) | 0 | 5,483,527 |